- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- kirilystherapeutics.com
- Last Round
- SeedJan 2022
- Rounds
- 1
About
Preclinical-stage biopharmaceutical company developing antibody-drug conjugates and CDK7 inhibitors for precision oncology.
Summary
Kirilys Therapeutics is a Biotech company based in United States, founded in 2021. Its most recent funding was a Seed round in Jan 2022. Investors include Lightspeed Venture Partners, Global Brain and Mercury Fund.
Funding History
Jan 2022
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kirilys-therapeutics"><img src="https://indexed.vc/api/badge/company/kirilys-therapeutics" alt="Kirilys Therapeutics on Indexed.vc" width="260" height="76" /></a>